Perspective · 29 Jul 2025
Conference abstractPublished 15 May 2023
Development of method validation for microbial identification using MALDI-TOF MS
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Recently, emerging industry trends in the biopharmaceutical industry have included drug discovery, drug development, biosimilar study, and drug manufacturing. Microbial contamination of biopharmaceuticals has inevitably been considered to be a significant issue for the process of manufacturing, negatively impacting the drug's potency, stability, and efficacy. Conventional standard microbiological methods, such as 16S rRNA gene sequencing, biochemical testing, etc., are currently used for routine monitoring of biopharmaceutical bacterial contaminants from water, air, and environmental surfaces. However, the rapid expansion of the biopharmaceutical growth has brought new challenges in reducing the time required for microbial identification. We developed the in-house method validation for microbial identification using MALDI-TOF MS. The qualitative parameters, specificity, precision, reproducibility, intermediate precision, and robustness were performed using 6 known microorganisms that are Bacillus subtilis subsp. subtilis TISTR 1460, Bacillus licheniformis TISTR 1109, Staphylococcus aureus NCTC 10788, Escherichia coli DH5-alpha, Pseudomonas aeruginosa DMST 15501 and Candida albican NCPF 3179. All organisms were cultured in LB agar and incubated at 30°C for 24-48 hours. The single colony of each strain was smeared on MALDI plate, overlaid with 70% Formic acid and 40 mg/ml α-cyano-4-hydroxycinnamic acid (CHCA) in Diluent solution (Acetonitrile, Ethanol, DI water type II, Trifluoroacetic acid (1:1:1:0.1 v/v)). After dried, sample coated MALDI plate was directly analyzed by MALDI-TOF MS, resulting peptide mass fingerprint (PMF) of sample. The PMF of each organism was then compared to the PMF of database to identify microorganism using SARAMIS. For both genera and species, MALDI-TOF MS had a 100% overall accuracy in identification. In all tests, the confidential value percentages (%CV) were higher than 90%, which was within accepted limits. The use of MALDI-TOF MS together with SARAMIS database has the capability to revolutionize microbial contamination identification and thus minimize the risk of microbial contamination occurring in biopharmaceutical production process. PDF HTML Digital File
Keywords
Subjects
Nursing & HealthcareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 18 Oct 2017
Rapid and reliable species identification of wild mushrooms by MALDI-TOF MS
Research article · 2012
Optimization of the SDS-PAGE gel slicing approach for identification of human liver microsomal proteins via MALDI-TOF mass spectrometry
Short communication · 29 Jan 2025
MALDI-TOF Protocol for M. tuberculosis Identification Improved MALDI-TOF MS Identification of Mycobacterium tuberculosis by Use of a Cell Disruption Protocol
Editorial · 24 Jan 2025
MALDI-TOF MS in Clinical Microbiology: Revolutionizing Pathogen Identification
More from this journal
The newest in Journal of Nursing Research and Practice.
Article · 17 Mar 2025
Enhancing nursing care quality: Strategies, challenges, and future directions
Article · 30 Sep 2024
GYMNEMA SYLVESTRE: A MEDICINAL PLANT WITH VERSATILE THERAPEUTIC APPLICATIONS
Article · 16 Sep 2024
Detection and enhancement of latent fingerprint by powder method using bio-synthesized spherical-shaped Bismuth Oxychloride nanoparticles
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nursing Research and Practice
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Thanawat Boontip”

